tradingkey.logo

Autonomix Medical Inc

AMIX
0.400USD
+0.002+0.40%
收盤 02/09, 16:00美東報價延遲15分鐘
422.36K總市值
虧損本益比TTM

Autonomix Medical Inc

0.400
+0.002+0.40%

關於 Autonomix Medical Inc 公司

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Inc簡介

公司代碼AMIX
公司名稱Autonomix Medical Inc
上市日期Jan 29, 2024
CEOHauser (Bradley)
員工數量8
證券類型Ordinary Share
年結日Jan 29
公司地址21 Waterway Ave, Suite 300
城市THE WOODLANDS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編77380
電話18322777816
網址https://autonomix.com/
公司代碼AMIX
上市日期Jan 29, 2024
CEOHauser (Bradley)

Autonomix Medical Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
+10982.00%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
10.98K
+10982.00%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 1月28日 週三
更新時間: 1月28日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
其他
91.46%
持股股東
持股股東
佔比
Klemp (Walter V.)
2.18%
BioStar Ventures III, L.P.
1.75%
Heights Capital Management, Inc.
1.68%
Toth (Landy)
1.47%
Mariner Wealth Advisors
1.46%
其他
91.46%
股東類型
持股股東
佔比
Individual Investor
4.96%
Investment Advisor
3.53%
Corporation
1.75%
Hedge Fund
0.89%
Venture Capital
0.20%
Investment Advisor/Hedge Fund
0.15%
其他
88.52%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
40
329.73K
4.77%
-157.15K
2025Q3
39
329.96K
7.93%
+35.06K
2025Q2
35
294.92K
16.34%
-135.37K
2025Q1
30
430.29K
14.58%
+71.16K
2024Q4
29
489.76K
8.72%
+336.46K
2024Q3
25
18.30K
0.40%
+13.75K
2024Q2
19
4.55K
0.18%
+2.81K
2024Q1
10
1.66K
0.00%
+1.66K

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Klemp (Walter V.)
150.75K
2.18%
--
--
Sep 19, 2025
BioStar Ventures III, L.P.
120.82K
1.75%
--
--
Jun 30, 2025
Heights Capital Management, Inc.
116.09K
1.68%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
1.47%
--
--
Sep 19, 2025
Mariner Wealth Advisors
100.64K
1.46%
--
--
Sep 30, 2025
Foster (Jonathan P.)
36.56K
0.53%
--
--
Sep 19, 2025
Schwartz (Robert)
35.77K
0.52%
--
--
Sep 19, 2025
Two Sigma Investments, LP
25.02K
0.36%
+25.02K
--
Sep 30, 2025
BMO Nesbitt Burns Inc.
25.00K
0.36%
+25.00K
--
Sep 30, 2025
Ikarian Capital LLC
20.00K
0.29%
--
--
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
公告日期
除權除息日
類型
比率
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
KeyAI